Fig. 4
From: A novel pThr217 tau monoclonal antibody reveals neuropathological heterogeneity in tauopathies
Immunohistochemical labelling of Alzheimer’s disease neuropathology. Immunohistochemical staining was performed as described in the “Materials and methods”. (a) Staining of AD and control frontal cortex tissue using monoclonal antibodies 7F2, AT180, 1F10, and AT100 is shown. Thin arrows indicate NFTs, arrow heads demonstrate neuritic plaques, thick arrows highlight neuropil threads. Scale bar of low magnification images is 100 μm, inset is 15 μm. (b) Semi-quantitative analysis of AD tau pathology in the frontal cortex is described in the “Materials and methods”. Data is presented as mean +/- SEM.
